This is also important because impaired executive function and working memory are common in persons with type-2 diabetes without dementia1, and amylin dysregulation is associated with type-2 diabetes and may be a possible contributing factor to these clinical effects. This evidence concerns the gene IAPP and type 2 diabetes mellitus.